<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="19673" end="19679" sStart="19635" offset="38" sid="r11.severe.j.0341" wn="5" wnkey="severe%5:00:00:critical:03" text="[ 22 ] observed that fever in severe septic shock patients' was reduced after ibuprofen administration." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-2-26.anc" start="15763" end="15768" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="In this study, the respiratory &lt;b&gt;rates&lt;/b&gt; of the study groups were significantly higher than the control group at 30 min." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-2-26.anc" start="15763" end="15768" sStart="null" offset="0" sid="null" wn="1" wnkey="rate%1:28:00::" text="In this study, the respiratory &lt;b&gt;rates&lt;/b&gt; of the study groups were significantly higher than the control group at 30 min." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="1559" end="1565" sStart="null" offset="73" sid="r9.normal.j.0655" wn="3" wnkey="normal%3:00:03::" text="Fink et al . [ 6 ] reported that ibuprofen restored the normal hemodynamic pattern." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="12850" end="12856" sStart="null" offset="2" sid="r9.level.n.0916" wn="2" wnkey="level%1:26:01::" text="2 levels were significantly increased at 30 min compared with t 0 (p &lt; 0.001)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="24075" end="24081" sStart="null" offset="4" sid="r9.level.n.0188" wn="2" wnkey="level%1:26:01::" text="Low levels of TxB 2 in group IV (at 0-30 min) were probably a result of ibuprofen inhibiting the increase which would normally be caused by these cytokines." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="8575" end="8581" sStart="null" offset="131" sid="r9.level.n.0850" wn="1" wnkey="level%1:07:00::" text="MAP levels showed an obvious decrease at 30 minutes in group II, which received only endotoxin from t 0 . MAP levels gradually decreased in group III, but showed a more regular gradual decrease in group IV." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="23530" end="23536" sStart="null" offset="22" sid="r9.level.n.0710" wn="1" wnkey="level%1:07:00::" text="Plasma TxB 2 levels were also reduced by introducing ibuprofen into the faecal peritonitis rat model used by Wise et al." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="23401" end="23407" sStart="null" offset="33" sid="r9.level.n.0494" wn="1" wnkey="level%1:07:00::" text="[ 28 ] reported that the levels of TxB 2 were significantly reduced in rats by a combination of TNF and ibuprofen." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="262" end="266" sStart="null" offset="37" sid="r10.high.j.0119" wn="1" wnkey="high%3:00:02::" text="The mortality rate can be as high as 60-70% in cases with multi-organ failure [ 1 ] , and several pharmacological agents have been used in an effort to reduce this percentage [ 2 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="25733" end="25738" sStart="null" offset="7" sid="r10.find.v.0781" wn="4" wnkey="find%2:32:00::" text="[ 30 ] found survival rates increased in mice treated with ibuprofen." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="12458" end="12465" sStart="null" offset="88" sid="r10.control.n.0747" wn="4" wnkey="control%1:09:02::" text="They were significantly different between Groups II and III and the control group, but no significant differences were detected between study groups (p &gt; 0.05, Table 4and Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="26795" end="26806" sStart="null" offset="89" sid="r11.combination.n.0753" wn="7" wnkey="combination%1:04:00::" text="Therefore, the use of ibuprofen at higher doses, over longer time periods, or in combination with other drugs in patients who are at risk of developing septic shock could be effective as a prophylaxis or treatment." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="25530" end="25537" sStart="null" offset="50" sid="r11.benefit.n.0856" wn="2" wnkey="benefit%1:07:00::" text="[ 32 ] found a transient 24-hour survival benefit in a rat model of septic shock." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-26.anc" start="26586" end="26593" sStart="null" offset="10" sid="r9.appear.v.0758" wn="1" wnkey="appear%2:39:00::" text="Ibuprofen appears to increase short-term survival due to its positive effect on various physiological parameters." />
  </sentences>
</list>